{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:38:04Z","timestamp":1792679884814,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.maturitas.2024.108153","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T17:08:52Z","timestamp":1730999332000},"page":"108153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Genetic associations of miRNA variants (miR-10a, miR-30c, miR-181a, miR-499b) with primary ovarian insufficiency in Korean women"],"prefix":"10.1016","volume":"191","author":[{"given":"Hui Jeong","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Soo","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Soo","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2024.108153_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/09513590.2015.1032933","article-title":"Are FSHR polymorphisms risk factors to premature ovarian insufficiency?","volume":"31","author":"Cordts","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.672890","article-title":"Premature ovarian insufficiency: past, present, and future","volume":"9","author":"Chon","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0015","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.fertnstert.2009.10.023","article-title":"A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency","volume":"94","author":"Hubayter","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2024.108153_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2020.11.004","article-title":"Premature ovarian insufficiency: a toolkit for the primary care physician","volume":"147","author":"Lambrinoudaki","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2024.108153_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/13697137.2020.1804547","article-title":"Premature ovarian insufficiency: an international menopause society white paper","volume":"23","author":"Panay","year":"2020","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2024.108153_bb0030","first-page":"32","article-title":"Premature ovarian insufficiency and infertility","volume":"52","author":"Dhanushi","year":"2023","journal-title":"Aust. J. Gen. Pract."},{"key":"10.1016\/j.maturitas.2024.108153_bb0035","article-title":"Selected genetic factors associated with primary ovarian insufficiency","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0040","first-page":"782","article-title":"FMR1 gene premutations: new insights and clinical consequences","volume":"6","author":"Sherman","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.maturitas.2024.108153_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ejhg.5201510","article-title":"D, Ward, a, Murray, nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers","volume":"14","author":"Ennis","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.maturitas.2024.108153_bb0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1472-6483(10)60388-4","article-title":"Screening for FOXL2 gene mutations in women with premature ovarian failure: an Indian experience","volume":"15","author":"Chatterjee","year":"2007","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.maturitas.2024.108153_bb0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0950-3536(05)80268-9","article-title":"Mechanisms of physiological fibrinolysis","volume":"8","author":"Lijnen","year":"1995","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1160\/TH05-01-0033","article-title":"Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease","volume":"93","author":"Dellas","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.maturitas.2024.108153_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleiotropic functions of plasminogen activator inhibitor-1","volume":"3","author":"Lijnen","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.maturitas.2024.108153_bb0070","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/ATVBAHA.107.149468","article-title":"Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study","volume":"27","author":"Morange","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2222.2009.03272.x","article-title":"Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation","volume":"39","author":"Ma","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.maturitas.2024.108153_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103490","article-title":"The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review","volume":"150","author":"Zhai","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10815-013-0171-2","article-title":"Plasminogen activator Inhibitor-1 -675 4G\/5G polymorphism and polycystic ovary syndrome risk: a Meta analysis","volume":"31","author":"Liu","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.maturitas.2024.108153_bb0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1160\/TH10-04-0243","article-title":"Allele-specific transcription of the PAI-1 gene in human astrocytes","volume":"104","author":"Hultman","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.maturitas.2024.108153_bb0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1530\/eje.0.1500793","article-title":"The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels","volume":"150","author":"Diamanti-Kandarakis","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0100","doi-asserted-by":"crossref","unstructured":"L.A Ram\u00f3n, J. Gilabert-Estell\u00e9s, R. Cos\u00edn, J. Gilabert, F. Espa\u00f1a, R. Castell\u00f3, M. Chirivella, A. Romeu, A. Estell\u00e9s, Plasminogen activator inhibitor-1 (PAI-1) 4G\/5G polymorphism and endometriosis influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression, Thromb. Res. 122 (2008) 854\u2013860.","DOI":"10.1016\/j.thromres.2008.02.010"},{"key":"10.1016\/j.maturitas.2024.108153_bb0105","first-page":"261","article-title":"MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for Cancer therapy: first steps from bench to bedside, target","volume":"15","author":"Ratti","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.maturitas.2024.108153_bb0110","first-page":"533","article-title":"MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy, genes","volume":"39","author":"Bong","year":"2017","journal-title":"Genomics"},{"key":"10.1016\/j.maturitas.2024.108153_bb0115","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1073\/pnas.1111241108","article-title":"Mir-290\u2013295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects","volume":"108","author":"Medeiros","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.maturitas.2024.108153_bb0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11102-010-0268-x","article-title":"MicroRNA profile indicates downregulation of the TGF pathway in sporadic non-functioning pituitary adenomas","volume":"14","author":"Butz","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.maturitas.2024.108153_bb0125","first-page":"226","article-title":"Genetic polymorphisms in miRNAs targeting the estrogen receptor and their effect on breast cancer risk, Meta","volume":"2","author":"Nguyen","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.maturitas.2024.108153_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1933719112450341","article-title":"Association of miR-146aC > G, miR-196a2T > C, and miR-499A > G polymorphisms with risk of premature ovarian failure in Korean women","volume":"20","author":"Rah","year":"2013","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-017-0256-3","article-title":"Role of microRNAs in premature ovarian insufficiency","volume":"15","author":"Guo","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0140","first-page":"615","article-title":"Characterization of microRNA expression profiles in cumulus cells and granulosa cells from women with polycystic ovary syndrome","volume":"447","author":"Xu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.maturitas.2024.108153_bb0145","first-page":"44","article-title":"BMP-15 and GDF-9 stimulate development of immature human oocytes and increase expression of ovarian follicular markers","volume":"6","author":"Wang","year":"2008","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2024.108153_bb0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/422103","article-title":"Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene","volume":"75","author":"Di Pasquale","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.maturitas.2024.108153_bb0155","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"Anti-M\u00fcllerian hormone (AMH): what do we still need to know?","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.maturitas.2024.108153_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1262\/jrd.2011-012","article-title":"Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells","volume":"58","author":"Matsuda","year":"2012","journal-title":"J. Reprod. Dev."},{"key":"10.1016\/j.maturitas.2024.108153_bb0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ymthe.2016.12.017","article-title":"miR-18a-5p inhibits sub-pleural pulmonary fibrosis by targeting TGF-b receptor II","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.maturitas.2024.108153_bb0170","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.12659\/MSM.910986","article-title":"miR-145-5p inhibits vascular smooth muscle cells (VSMCs) proliferation and migration by dysregulating the transforming growth factor-\u03b2 signaling cascade","volume":"24","author":"Li","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"9","key":"10.1016\/j.maturitas.2024.108153_bb0175","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/GME.0000000000000659","article-title":"The miR-449b polymorphism, rs10061133 a>G, is associated with premature ovarian insufficiency","volume":"23","author":"Pan","year":"2016","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.maturitas.2024.108153_bb0180","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/ijms18061255","article-title":"Association of miR-938G>a polymorphisms with primary ovarian insufficiency (POI)-related gene expression","volume":"18","author":"Cho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0185","article-title":"Associations of functional MicroRNA binding site polymorphisms in IL23\/Th17 inflammatory pathway genes with gastric Cancer risk","volume":"6974696","author":"Dong","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.maturitas.2024.108153_bb0190","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.2147\/CMAR.S326732","article-title":"MiR-10a-5p: a promising biomarker for early diagnosis and prognosis evaluation of bladder Cancer","volume":"13","author":"Yang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.maturitas.2024.108153_bb0195","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4049\/jimmunol.1502006","article-title":"MicroRNA-30c modulates type I IFN responses to facilitate porcine reproductive and respiratory syndrome virus infection by targeting JAK1","volume":"196","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.maturitas.2024.108153_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3892\/ijo.2023.5556","article-title":"Role of miR-181a-5p in cancer (review)","volume":"63","author":"Li","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"20","key":"10.1016\/j.maturitas.2024.108153_bb0205","first-page":"6220","article-title":"MiR-499b-5p inhibits cervical cancer cell proliferation and induces apoptosis by targeting the Notch1 signaling pathway","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.maturitas.2024.108153_bb0210","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.18632\/oncotarget.7002","article-title":"A SNP in pri-miR-10a is associated with recurrent spontaneous abortion in a Han-Chinese population","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.maturitas.2024.108153_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106278","article-title":"Adipocyte-derived exosomal miR-30c-5p promotes ovarian angiogenesis in polycystic ovary syndrome via the SOCS3\/STAT3\/VEGFA pathway","volume":"230","author":"Hu","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0220","first-page":"19","article-title":"MicroRNA control of TGF- signaling","volume":"28","author":"Suzuki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"46","key":"10.1016\/j.maturitas.2024.108153_bb0225","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e336","article-title":"Identification of single nucleotide polymorphisms as biomarkers for recurrent pregnancy loss in Korean women","volume":"37","author":"Kim","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0230","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1158\/0008-5472.CAN-07-2377","article-title":"Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer","volume":"67","author":"Sauna","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.maturitas.2024.108153_bb0235","first-page":"1439","article-title":"Polymorphisms in human pre-miRNAs","volume":"331","author":"Iawi","year":"2005","journal-title":"Biochem. Biophys."},{"key":"10.1016\/j.maturitas.2024.108153_bb0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/humu.21044","article-title":"Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population","volume":"30","author":"Xu","year":"2009","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.maturitas.2024.108153_bb0245","first-page":"6127","article-title":"Genetic variations miR-10aA>T, miR-30cA>G, miR-181aT>C, and miR-499bA>G and the risk of recurrent pregnancy loss in Korean women","volume":"22","author":"An","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.maturitas.2024.108153_bb0250","article-title":"miR-30c regulates proliferation, apoptosis and differentiation via the Shh signaling pathway in P19 cells","volume":"29","author":"Liu","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.maturitas.2024.108153_bb0255","first-page":"19","article-title":"MicroRNA control of TGF-signaling","volume":"28","author":"Suzuki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110603","article-title":"miR-181a promotes porcine granulosa cell apoptosis by targeting TGFBR1 via the activin signaling pathway","volume":"499","author":"Zhang","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/j.maturitas.2024.108153_bb0265","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1007\/s11033-023-08755-0","article-title":"MicroRNA-499-5p inhibits transforming growth factor-\u03b21-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGF\u03b2-R1","volume":"50","author":"Zhao","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.maturitas.2024.108153_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2022.03.011","article-title":"Downregulation of miR-33a\/b and miR-181a contributes to recurrent pregnancy loss by upregulating S1PR1 and repressing regulatory T cell differentiation","volume":"121","author":"Geng","year":"2022","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.maturitas.2024.108153_bb0275","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/GME.0000000000001258","article-title":"The association of miR-25T>C, miR-32C>a, miR-125C>T, and miR-222G>T polymorphisms with a risk of primary ovarian insufficiency in Korean women","volume":"26","author":"Cho","year":"2019","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.maturitas.2024.108153_bb0280","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/ijms18061255","article-title":"Association of miR-938G>a polymorphisms with primary ovarian insufficiency (POI)-related gene expression","volume":"18","author":"Cho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0285","first-page":"604","article-title":"Incidence of premature ovarian failure","volume":"67","author":"Coulam","year":"1986","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2024.108153_bb0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1750-1172-1-9","article-title":"Premature ovarian failure","volume":"1","author":"Beck-Peccoz","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.maturitas.2024.108153_bb0295","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2004-1985","article-title":"Selective theca cell dysfunction in autoimmune oophoritis in multifollicular development, decreased estrogen, elevated inhibin B levels","volume":"90","author":"Welt","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2024.108153_bb0300","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.3390\/ijms22179336","article-title":"The role of noncoding RNA in the pathophysiology and treatment of premature ovarian insufficiency","volume":"22","author":"Pankiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2024.108153_bb0305","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41419-017-0163-8","article-title":"Y, Qin, MicroRNA-379-5p is associate with biochemical premature ovarian insufficiency through PARP1 and XRCC6","volume":"9","author":"Dang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.maturitas.2024.108153_bb0310","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1210\/clinem\/dgad070","article-title":"Recent insights into noncoding RNAs in primary ovarian insufficiency: focus on mechanisms and treatments","volume":"108","author":"Zhang","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2024.108153_bb0315","first-page":"5045873","article-title":"Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying MicroRNA-29a improves ovarian function of mice with primary ovarian insufficiency by targeting HMG-box transcription factor\/Wnt\/\u03b2-catenin signaling","volume":"2","author":"Gao","year":"2022","journal-title":"Dis. Markers"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224002482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224002482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:36:51Z","timestamp":1732808211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512224002482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":63,"alternative-id":["S0378512224002482"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.108153","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic associations of miRNA variants (miR-10a, miR-30c, miR-181a, miR-499b) with primary ovarian insufficiency in Korean women","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.108153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108153"}}